Literature DB >> 23073799

Isolation and identification of cancer stem-like cells from side population of human prostate cancer cells.

Yatong Chen1, Jiahui Zhao1, Yong Luo1, Yongxing Wang1, Nengbao Wei1, Yongguang Jiang2.   

Abstract

It has been widely verified by various sorting methods that cancer stem cells (CSCs) exist in different types of tumor cells or tissues. However, due to lack of specific stem cell surface markers, CSCs are very difficult to be separated from some cancer cells, which becomes the key barrier of functional studies of CSCs. The sorting method by side population cells (SP) lays a solid foundation for in-depth and comprehensive study of CSCs. To identify the existence of SP in prostate cancer cell lines, we applied flow cytometry sorting by SP to cultures of prostate cancer cell lines (TSU, LnCap, and PC-3), and the cancer stem-like characteristics of SP were verified through experiments in vitro and in vivo. The proportion of SP in TSU cells was calculated to be 1.60%±0.40% [Formula: see text], and that in PC-3 and LnCap cells was calculated to be 0.80%±0.05% and 0.60%±0.20%, respectively. The colony formation assay demonstrated that the colony formation rate of SP to non-SP sorted from TSU via flow cytometry was 0.495±0.038 to 0.177±0.029 in 500 cells, 0.505±0.026 to 0.169±0.024 in 250 cells, and 0.088±0.016 to 0.043±0.012 in 125 cells respectively. In the in vivo experiments, tumors were observed in all the mice on the 10th day after injecting 50 000 cells subcutaneously in SP group, whereas when 5×10(6) cells were injected in non-SP group, tumors were developed in only 4 out of 8 mice until the 3rd week before the end of the experiment. Our results revealed that prostate cancer cells contain a small subset of cells, called SP, possessing much greater capacity of colony formation and tumorigenic potential than non-SP. These suggest that SP in prostate cancer cells may play a key role in the self-renewal and proliferation, and have the characteristics of cancer stem-like cells. Dissecting these features will provide a new understanding of the function of prostate CSCs in tumorigenicity and transformation.

Entities:  

Mesh:

Year:  2012        PMID: 23073799     DOI: 10.1007/s11596-012-1020-8

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  39 in total

Review 1.  Translating basic research in cancer patient care.

Authors:  Marcello Maugeri-Saccà; Ruggero De Maria
Journal:  Ann Ist Super Sanita       Date:  2011       Impact factor: 1.663

2.  Unstable side population phenotype of mouse spermatogonial stem cells in vitro.

Authors:  Takashi Shinohara; Kei Ishii; Mito Kanatsu-Shinohara
Journal:  J Reprod Dev       Date:  2011-01-06       Impact factor: 2.214

3.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.

Authors:  M A Goodell; M Rosenzweig; H Kim; D F Marks; M DeMaria; G Paradis; S A Grupp; C A Sieff; R C Mulligan; R P Johnson
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

4.  Targeting the Hedgehog pathway in cancer.

Authors:  Sachin Gupta; Naoko Takebe; Patricia Lorusso
Journal:  Ther Adv Med Oncol       Date:  2010-07       Impact factor: 8.168

Review 5.  The ABCG2 resistance network of glioblastoma.

Authors:  Anne-Marie Bleau; Jason T Huse; Eric C Holland
Journal:  Cell Cycle       Date:  2009-09-13       Impact factor: 4.534

6.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

7.  CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature.

Authors:  Anjali P Kusumbe; Avinash M Mali; Sharmila A Bapat
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

8.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

9.  MicroRNAs involved in neoplastic transformation of liver cancer stem cells.

Authors:  Ren Li; Niansong Qian; Kaishan Tao; Nan You; Xinchuan Wang; Kefeng Dou
Journal:  J Exp Clin Cancer Res       Date:  2010-12-23

10.  Functional and molecular characterisation of mammary side population cells.

Authors:  Azra J Alvi; Helen Clayton; Chirag Joshi; Tariq Enver; Alan Ashworth; Maria d M Vivanco; Trevor C Dale; Matthew J Smalley
Journal:  Breast Cancer Res       Date:  2002-10-14       Impact factor: 6.466

View more
  3 in total

1.  Isolation of side population cells from endometrial cancer cells using a violet laser diode.

Authors:  Satoshi Tomiyasu; Tomoyuki Miyamoto; Michihiro Mori; Takahiro Yaguchi; Hiromasa Yakushiji; Setsuyo Ohno; Yasuyuki Miyake; Takuya Sakaguchi; Masatsugu Ueda; Eiji Ohno
Journal:  Hum Cell       Date:  2013-10-04       Impact factor: 4.174

2.  NRP1-positive lung cancer cells possess tumor-initiating properties.

Authors:  Luis E Jimenez-Hernandez; Karla Vazquez-Santillan; Rosario Castro-Oropeza; Gustavo Martinez-Ruiz; Laura Muñoz-Galindo; Carolina Gonzalez-Torres; Carlo C Cortes-Gonzalez; Georgina Victoria-Acosta; Jorge Melendez-Zajgla; Vilma Maldonado
Journal:  Oncol Rep       Date:  2017-11-09       Impact factor: 3.906

3.  Characterization of prostate cancer cell progression in zebrafish xenograft model.

Authors:  Wei Xu; Brittany A Foster; Mackenzie Richards; Kenneth R Bondioli; Girish Shah; Christopher C Green
Journal:  Int J Oncol       Date:  2017-11-06       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.